Pituitary Neoplasm
8
1
1
5
Key Insights
Highlights
Success Rate
71% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 87/100
25.0%
2 terminated out of 8 trials
71.4%
-15.1% vs benchmark
0%
0 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (8)
Feasibility of Endosphenoidal Coil Placement for Imaging of the Sella During Transsphenoidal Surgery
The Treatment and Natural History of Acromegaly
Evaluation of Patients With Endocrine-Related Conditions
Rhinological Outcomes in Endonasal Pituitary Surgery
Effects of Hormone Stimulation on Brain Scans for Cushing s Disease
Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin
Sandostatin LAR Depot vs. Surgery for Treating Acromegaly
Evaluation of Factors in Human Brain Tumors